Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|10|1083-1091

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.10, 2004-04, pp. : 1083-1091

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitogen-Activated Protein Kinases: New Molecular Targets for Pharmacological Treatment of Inflammatory Lung Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 2, 2003-06 ,pp. : 131-141

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Targets for Anti-Inflammatory Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1396-1409

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite